» Articles » PMID: 39334413

Forward-reverse Mutation Cycles in Cancer Cell Lines Under Chemical Treatments

Overview
Journal Hum Genomics
Publisher Biomed Central
Specialty Genetics
Date 2024 Sep 28
PMID 39334413
Authors
Affiliations
Soon will be listed here.
Abstract

Spontaneous forward-reverse mutations were reported by us earlier in clinical samples from various types of cancers and in HeLa cells under normal culture conditions. To investigate the effects of chemical stimulations on such mutation cycles, the present study examined single nucleotide variations (SNVs) and copy number variations (CNVs) in HeLa and A549 cells exposed to wogonin-containing or acidic medium. In wogonin, both cell lines showed a mutation cycle during days 16-18. In acidic medium, both cell lines displayed multiple mutation cycles of different magnitudes. Genomic feature colocalization analysis suggests that CNVs tend to occur in expanded and unstable regions, and near promoters, histones, and non-coding transcription sites. Moreover, phenotypic variations in cell morphology occurred during the forward-reverse mutation cycles under both types of chemical treatments. In conclusion, chemical stresses imposed by wogonin or acidity promoted cyclic forward-reverse mutations in both HeLa and A549 cells to different extents.

Citing Articles

Evolving Artificial Intelligence (AI) at the Crossroads: Potentiating Productive vs. Declining Disruptive Cancer Research.

Sharma N, Sarode S Cancers (Basel). 2024; 16(21).

PMID: 39518084 PMC: 11544874. DOI: 10.3390/cancers16213646.

References
1.
Sun X, Yu Q . Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment. Acta Pharmacol Sin. 2015; 36(10):1219-27. PMC: 4648179. DOI: 10.1038/aps.2015.92. View

2.
Klevebring D, Rosin G, Ma R, Lindberg J, Czene K, Kere J . Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo. Breast Cancer Res. 2014; 16(4):R72. PMC: 4227057. DOI: 10.1186/bcr3687. View

3.
Long X, Xue H . Genetic-variant hotspots and hotspot clusters in the human genome facilitating adaptation while increasing instability. Hum Genomics. 2021; 15(1):19. PMC: 7976700. DOI: 10.1186/s40246-021-00318-3. View

4.
Mumenthaler S, Foo J, Choi N, Heise N, Leder K, Agus D . The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells. Cancer Inform. 2015; 14(Suppl 4):19-31. PMC: 4504404. DOI: 10.4137/CIN.S19338. View

5.
Heppner G, Miller B . Tumor heterogeneity: biological implications and therapeutic consequences. Cancer Metastasis Rev. 1983; 2(1):5-23. DOI: 10.1007/BF00046903. View